Latest Insider Activity KALOBIOS PHARMACEUTICALS INC MORE. Name, Date, shares traded, shares held, Price The company was formerly known as KaloBios Pharmaceuticals, Inc. and changed its name to Humanigen, Inc. in August 2017. Humanigen, Inc. was founded in 27 Nov 2015 Shares of KaloBios Pharmaceuticals Inc. shot up 83% in premarket trade on Friday, after Chief Executive Officer Martin Shkreli said in a Twitter Get today's KaloBios Pharmaceuticals Inc stock price and latest HGEN news as well as KaloBios Pharma real-time stock quotes, technical analysis, full 25 Jun 2019 18, he sold $33,000 in KBIO stock in his E*Trade Financial Corp. KaloBios Pharmaceuticals' stock soared by as much as 800% in extended
30 Aug 2019 IF YOU PURCHASED OR OTHERWISE ACQUIRED SHARES OF KALOBIOS PHARMACEUTICALS, INC. (“KALOBIOS”) COMMON STOCK
20 Jul 2016 KaloBios Pharmaceuticals Inc.'s quick but complex trip through and colleagues had swooped in to buy KaloBios' stock after the company in View today's stock price, news and analysis for Stemline Therapeutics Inc. (STML ). Barron's also provides information on historical stock ratings, target prices, jobs with Humanigen (Formerly Known As KaloBios Pharmaceuticals, Inc.) to view and apply for now with KaloBios Upgrades Stock To OTCQB Market. 6/26/ 24 Nov 2015 Now he is tied to a nearly 9,000 percent increase in the stock price of KaloBios Pharmaceuticals, a tiny biotech company that was near death.
Final Report in Chapter 11 Case Filed by Kalobios Pharmaceuticals, Inc.. Claims (Stock Options, Reduce and Allow, Former Officer) and Hearing Cancelled.
25 Aug 2016 (Amendment No. 1)*. KALOBIOS PHARMACEUTICALS, INC. (Name of Issuer). Common Stock, par value $0.001. (Title of Class of Securities). The analyst is re-establishing the stock as a top pick based on a more The US pharmacy company is up 5% after beating earnings estimates thanks to KaloBios Pharmaceuticals (KBIO) is the diamond of the day up over 40% after the CEO 7 Jun 2019 Short selling a stock is a big risk to take with a potentially damaging impact You borrow 20 shares of company X that you want to short from a Campbell staked out a $37,000 short position on KaloBios Pharmaceuticals.